Citations

Clear

4847 citation(s) found for "Tu, Eric".

Examination of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation in former elite American football players
Miner, Annalise E. , Groh, Jenna R. , Balcer, Laura J. , Bernick, Charles , Zetterberg, Henrik, Blennow, Kaj, Peskind, Elaine R. , Martin, Brett , Palmisano, Joseph , Banks, Sarah J. , Wethe, Jennifer V. , Amerongen, Suzan van , Shenton, Martha E. , Reiman, Eric M. , Alosco, Michael L. , Wethe, Jennifer V , Shenton, Martha E , Tripodis, Yorghos , Adler, Charles H. , Zetterberg, Henrik , Blennow, Kaj , Ashton, Nicholas J. , Gaudet, Charles E. , Barr, William , Cantu, Robert C. , Dodick, David W. , Katz, Douglas I. , Mez, Jesse , Cummings, Jeffrey L. , Stern, Robert A.

Mayo Clinic

Alzheimer's & Dementia | October 1, 2024 | Volume: 20 | Issue: 11 | Pages: 7529-7546

10.1002/alz.14231 | PMID 39351900 Get It

AbstractINTRODUCTIONBlood‐based biomarkers offer a promising approach for the detection of neuropathologies from repetitive head impacts (RHI). We evaluated plasma biomarkers of amyloid, tau, neurodegeneration, and inflammation in former football players.METHODSThe sample included 180 former football players and 60 asymptomatic, unexposed male participants (aged 45–74). Plasma assays were conducted for beta‐amyloid (Aβ) 40, Aβ42, hyper‐phosphorylated tau (p‐tau) 181+231, total tau (t‐tau), neurofilament light (NfL), glial fibrillary acidic protein (GFAP), interleukin‐6 (IL‐6), Aβ42/p‐tau181 and Aβ42/Aβ40 ratios. We evaluated their ability to differentiate the groups and associations with RHI proxies and traumatic encephalopathy syndrome (TES).RESULTSP‐tau181 and p‐tau231(padj = 0.016) were higher and Aβ42/p‐tau181 was lower(padj = 0.004) in football players compared to controls. Discrimination accuracy for p‐tau was modest (area under the curve [AUC] = 0.742). Effects were not attributable to AD‐related pathology. Younger age of first exposure (AFE) correlated with higher NfL (padj = 0.03) and GFAP (padj = 0.033). Plasma GFAP was higher in TES‐chronic traumatic encephalopathy (TES‐CTE) Possible/Probable (padj = 0.008).DISCUSSIONPlasma p‐tau181 and p‐tau231, GFAP, and NfL may offer some usefulness for the characterization of RHI‐related neuropathologies.Highlights Former football players had higher plasma p‐tau181 and p‐tau231 and lower Aβ42/ptau‐181 compared to asymptomatic, unexposed men. Younger age of first exposure was associated with increased plasma NfL and GFAP in older but not younger participants. Plasma GFAP was higher in participants with TES‐CTE possible/probable compared to TES‐CTE no/suggestive.
Association of Hepatorenal Syndrome-Acute Kidney Injury with Mortality in Patients with Cirrhosis Requiring Renal Replacement Therapy
Cama-Olivares, Augusto , Ouyang, Tianqi , Takeuchi, Tomonori , Hillien, Shelsea A. St., Robinson, Jevon E. , Cullaro, Giuseppe , Karvellas, Constantine , Levitsky, Josh , Orman, Eric S. , Patidar, Kavish R. , Regner, Kevin R. , Saly, Danielle L. , Teixeira, J. Pedro , Velez, Juan Carlos Q. , Wahid, Nabeel , Allegretti, Andrew S. , Neyra, Javier A. , Belcher, Justin M. , Cullaro, Giuseppe , Karvellas, Constantine , Orman, Eric S , Sawinski, Deirdre , Teixeira, J Pedro , Ufere, Nneka N , Velez, Juan Carlos Q , Wadei, Hani M , Wahid, Nabeel , Neyra, Javier A , Belcher, Justin M , Patidar, Kavish R , Chung, Raymond T. , Sharma, Pratima , Wadei, Hani M.

Mayo Clinic

Kidney360 | September 30, 2024 | Volume: 6 | Issue: 2 | Pages: 247-256

10.34067/kid.0000000589 | PMID 39348201 Get It

Key Points In patients with cirrhosis and AKI requiring renal replacement therapy (RRT), hepatorenal syndrome-AKI was not associated with an increased 90-day mortality when compared with other AKI etiologies. Etiology of AKI may not be a critical factor regarding decisions to trial RRT in acutely ill patients with cirrhosis and AKI. Although elevated, mortality rates in this study are comparable with those reported in general hospitalized patients with AKI requiring RRT. Background While AKI requiring renal replacement therapy (AKI-RRT) is associated with increased mortality in heterogeneous inpatient populations, the epidemiology of AKI-RRT in hospitalized patients with cirrhosis is not fully known. Herein, we evaluated the association of etiology of AKI with mortality in hospitalized patients with cirrhosis and AKI-RRT in a multicentric contemporary cohort. Methods This is a multicenter retrospective cohort study using data from the HRS-HARMONY consortium, which included 11 US hospital network systems. Consecutive adult patients admitted in 2019 with cirrhosis and AKI-RRT were included. The primary outcome was 90-day mortality, and the main independent variable was AKI etiology, classified as hepatorenal syndrome (HRS-AKI) versus other (non–HRS-AKI). AKI etiology was determined by at least two independent adjudicators. We performed Fine and Gray subdistribution hazard analyses adjusting for relevant clinical variables. Results Of 2063 hospitalized patients with cirrhosis and AKI, 374 (18.1%) had AKI-RRT. Among them, 65 (17.4%) had HRS-AKI and 309 (82.6%) had non–HRS-AKI, which included acute tubular necrosis in most cases (62.6%). Continuous renal replacement therapy was used as the initial modality in 264 (71%) of patients, while intermittent hemodialysis was used in 108 (29%). The HRS-AKI (versus non–HRS-AKI) group received more vasoconstrictors for HRS management (81.5% versus 67.9%), whereas the non–HRS-AKI group received more mechanical ventilation (64.3% versus 50.8%) and more continuous renal replacement therapy (versus intermittent hemodialysis) as the initial RRT modality (73.9% versus 56.9%). In the adjusted model, HRS-AKI (versus non–HRS-AKI) was not independently associated with increased 90-day mortality (subdistribution hazard ratio, 1.36; 95% confidence interval, 0.95 to 1.94). Conclusions In this multicenter contemporary cohort of hospitalized adult patients with cirrhosis and AKI-RRT, HRS-AKI was not independently associated with an increased risk of 90-day mortality when compared with other AKI etiologies. The etiology of AKI appears less relevant than previously considered when evaluating the prognosis of hospitalized adult patients with cirrhosis and AKI requiring RRT.
Review of Novel Surgical, Radiation, and Systemic Therapies and Clinical Trials in Glioblastoma
Valerius, Allison R. , Webb, Lauren M. , Thomsen, Anna, Lehrer, Eric J. , Breen, William G. , Campian, Jian , Riviere-Cazaux, Cécile , Burns, Terry C. , Sener, Uğur , Burns, Terry C , Sener, Ugur , Webb, Lauren Michelle , Valerius, Allison

Mayo Clinic

International Journal of Molecular Sciences | September 30, 2024 | Volume: 25 | Issue: 19 | Pages: 10570

10.3390/ijms251910570 | PMID 39408897 Get It

Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. Despite an established standard of care including surgical resection, radiation therapy, and chemotherapy, GBM unfortunately is associated with a dismal prognosis. Therefore, researchers are extensively evaluating avenues to expand GBM therapy and improve outcomes in patients with GBM. In this review, we provide a broad overview of novel GBM therapies that have recently completed or are actively undergoing study in clinical trials. These therapies expand across medical, surgical, and radiation clinical trials. We additionally review methods for improving clinical trial design in GBM.
Symptomatic Pneumorrhachis from Bronchial-Subarachnoid Fistula
Lipinski, Alexander W. , Smith, Mathew V. , Wannamaker, Eric J., Timpone, Vincent M. , Smith, Mathew

Mayo Clinic

Diagnostics | September 30, 2024 | Volume: 14 | Issue: 19 | Pages: 2170

10.3390/diagnostics14192170 | PMID 39410574 Get It

Bronchial-subarachnoid fistulas are rare occurrences, which are not well defined in the literature. This uncommon clinical phenomenon may result in symptomatic pneumorrhachis and presents unique clinical challenges. This report details a case of a 53-year-old female whose treatment for recurrent chondrosarcoma of the thoracic spine included multiple surgeries and radiotherapy. Two weeks after her most recent debulking surgery, she experienced a rapid onset of unusual symptoms, including headache, back and neck spasms, bladder incontinence, and confusion. The source of her symptoms was found to be secondary to pneumorrhachis from a pre-existing bronchial-pleural fistula that had fistulized to the subarachnoid space discovered on computed tomography (CT) and confirmed intraoperatively. The patient was treated successfully with high-flow oxygen therapy and bed rest, followed by surgical correction of both a pleural air leak and a dural defect with muscular flaps. The patient was discharged home in stable condition and remained clinically free of recurrent bronchial-subarachnoid fistula six months after surgical repair. This case contributes to the existing literature by providing detailed clinical insights into the diagnosis and successful management of a bronchial-subarachnoid fistula leading to pneumorrhachis, thereby highlighting the importance of early recognition and intervention and underscoring the need for further research in this area.
Harnessing the Power of Generative Artificial Intelligence in Pathology Education: Opportunities, Challenges, and Future Directions
Cecchini, Matthew J. , Borowitz, M, Glassy, Eric F., Gullapalli, Rama R. , Hassell, Lewis , Jackups, Ronald , McNeal, Jeffrey L., Anderson, Scott R. , Hart, Steven N. , Homer, Robert , McNeal, Jeffrey L.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | September 29, 2024 | Volume: 149 | Issue: 2 | Pages: 142-151

10.5858/arpa.2024-0187-ra | PMID 39343982 Get It

Context.— Generative artificial intelligence (AI) technologies are rapidly transforming numerous fields, including pathology, and hold significant potential to revolutionize educational approaches. Objective.— To explore the application of generative AI, particularly large language models and multimodal tools, for enhancing pathology education. We describe their potential to create personalized learning experiences, streamline content development, expand access to educational resources, and support both learners and educators throughout the training and practice continuum. Data Sources.— We draw on insights from existing literature on AI in education and the collective expertise of the coauthors within this rapidly evolving field. Case studies highlight practical applications of large language models, demonstrating both the potential benefits and unique challenges associated with implementing these technologies in pathology education. Conclusions.— Generative AI presents a powerful tool kit for enriching pathology education, offering opportunities for greater engagement, accessibility, and personalization. Careful consideration of ethical implications, potential risks, and appropriate mitigation strategies is essential for the responsible and effective integration of these technologies. Future success lies in fostering collaborative development between AI experts and medical educators, prioritizing ongoing human oversight and transparency to ensure that generative AI augments, rather than supplants, the vital role of educators in pathology training and practice.
Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
Mendoza, Maria A. , Bhaimia, Eric , Razonable, Raymund R. , Thoendel, Matthew , Mendoza, Maria Alejandra , Razonable, Raymund R , Alkhateeb, Hassan B.

Mayo Clinic

Transplant Infectious Disease | September 28, 2024 | Volume: 26 | Issue: 6 | Pages: No page available

10.1111/tid.14377 | PMID 39340371 Get It

AbstractIntroductionCytomegalovirus (CMV) reactivation is one of the most common complications after allogeneic hematopoietic stem cell transplantation (HSCT). Letermovir is approved for CMV prophylaxis among high‐risk recipients. However, delayed‐onset post‐prophylaxis clinically significant CMV infection (csCMVi) has been observed, suggesting the potential for extending letermovir prophylaxis beyond the first one hundred days post‐HSCT.MethodsRetrospective multicenter cohort study of allogeneic HSCT patients from August 2018 to March 2023. The primary aim of this study was to identify the risk factors at day 100 associated with delayed onset csCMVi, in patients who received letermovir prophylaxis up to day 100. Competing risk analysis was used to evaluate incidence with specific risk factors, using Gray's Test comparing groups for each event.ResultsAmong 166 eligible allogeneic HSCT recipients, the most common primary hematological diagnosis was acute myelogenous leukemia (AML) (42.2%). Twenty‐six (15.7%) developed a breakthrough csCMVi. Delayed‐onset csCMVi occurred in 23.5%, at a median time of 133 days after SCT. On multivariate analysis, having a matched unrelated donor (odds ratio [OR] 2.46) and a CMV donor negative/recipient positive status (OR 3.47) were associated with delayed onset csCMVi. In contrast, AML had a lower odd of having delayed‐onset csCMVi (OR 0.23).ConclusionsHaving a matched unrelated donor, a CMV donor negative/recipient positive status, and a non‐AML underlying disease were associated with delayed onset csCMVi. Prospective studies are needed to evaluate whether extended letermovir prophylaxis is beneficial for these patients. image
ASHP and ASHP Foundation Pharmacy Forecast 2025: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems
Hoffman, James M. , Tichy, Eric M. , Shea, Suzanne, Sanborn, Michael, Fox, Erin R. , Torrise, Virginia, Abourjaily, Paul , Cunningham, Francesca , Schweitzer, Pamela, Nelson, Scott D. , Stump, Lisa S, Castro, Harvey, Nesbit, Todd, Scott, Christopher M., Tichy, Eric, DiPiro, Joseph T. , Shea, Suzanne, Hung, Anna , Watanabe, Jonathan Hirohiko , Stump, Lisa S. , Castro, Harvey

Mayo Clinic

American Journal of Health-System Pharmacy | September 27, 2024 | Volume: 82 | Issue: 2 | Pages: 17-47

10.1093/ajhp/zxae280 | PMID 39657700 Get It

Abstract Purpose The 2025 ASHP Pharmacy Forecast report is written to identify and contextualize emerging trends that will influence healthcare, health systems, and the pharmacy profession. It provides recommendations to inform strategic planning that should prompt action by pharmacists and health-system leaders. Methods Drawing on the “wisdom of crowds” concept, a survey was constructed by an advisory committee with 6 themes, each with 7 focused statements and a seventh theme on preparedness (54 survey items in total). A survey panel of 321 pharmacy leaders was purposefully designed to capture opinions from a wide range of pharmacists across the United States. Panelists were asked to consider the likelihood of the statements occurring in the next 5 years as being likely, somewhat likely, somewhat unlikely, or very unlikely to occur. Forecast panelists also assessed health systems’ preparedness (from very unprepared to very prepared) for 12 of the statements. Results The 6 survey themes identified were The Business of Healthcare: Challenges in Health-System Pharmacy, Managing Ultra-High-Cost Drugs, Addressing the Gap in Primary Care, Whole Person Health, Navigating Generative Artificial Intelligence: Opportunity and Risk, and Stabilizing the Pharmacy Workforce. The survey was completed by 269 respondents, yielding an 84% response rate. Descriptive statistics of the survey results were provided to chapter authors to inform commentary and strategic recommendations for each theme. Conclusion The Pharmacy Forecast provides insights on large-scale, long-term trends that will influence healthcare and the pharmacy profession over the years ahead. Insight from the report can stimulate strategic thinking and provides a starting point to proactively position leaders, their teams, and departments for potential future trends.
Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's disease
Sewell, Kelsey R. , Xiong, Chengjie , Masters, Colin L. , Laske, Christoph , Huey, Edward D. , Hassenstab, Jason , Day, Gregory S. , Fox, Nick C. , Chhatwal, Jasmeer P. , Roh, Jee Hoon , Perrin, Richard J. , Supnet, Charlene , Berman, Sarah , Daniels, Alisha , Noble, James M. , Martins, Ralph N. , Gardener, Samantha L. , Morris, John C. , Erickson, Kirk I. , Sohrabi, Hamid R. , Brown, Belinda M. , Network, The Dominantly Inherited Alzheimer's, Day, Gregory S , Masters, Colin L , Xiong, Chengjie , Fox, Nick C , Hassenstab, Jason , Morris, John C , Roh, Jee Hoon , Supnet-Bell, Charlene , Berman, Sarah , Noble, James M , Doecke, James D. , Xiong, Chengjie , Benzinger, Tammie L.S. , Jucker, Mathias , Lopera, Francisco Javier , Gordon, Brian A. , Llibre‐Guerra, Jorge J. , Schofield, Peter R. , Ibanez, Laura , Lee, Jae‐Hong , Allegri, Ricardo , Rainey‐Smith, Stephanie R. , Peiffer, Jeremiah J. , Bateman, Randall J. , McDade, Eric , Network, The Dominantly Inherited Alzheimer's

Mayo Clinic

Alzheimer's & Dementia | September 26, 2024 | Volume: 20 | Issue: 11 | Pages: 7923-7939

10.1002/alz.14270 | PMID 39324510 Get It

AbstractINTRODUCTIONWe investigated longitudinal associations between self‐reported exercise and Alzheimer's disease (AD)‐related biomarkers in individuals with autosomal dominant AD (ADAD) mutations.METHODSParticipants were 308 ADAD mutation carriers aged 39.7 ± 10.8 years from the Dominantly Inherited Alzheimer's Network. Weekly exercise volume was measured via questionnaire and associations with brain volume (magnetic resonance imaging), cerebrospinal fluid biomarkers, and brain amyloid beta (Aβ) measured by positron emission tomography were investigated.RESULTSGreater volume of weekly exercise at baseline was associated with slower accumulation of brain Aβ at preclinical disease stages β = –0.16 [–0.23 to –0.08], and a slower decline in multiple brain regions including hippocampal volume β = 0.06 [0.03 to 0.08].DISCUSSIONExercise is associated with more favorable profiles of AD‐related biomarkers in individuals with ADAD mutations. Exercise may have therapeutic potential for delaying the onset of AD; however, randomized controlled trials are vital to determine a causal relationship before a clinical recommendation of exercise is implemented.Highlights Greater self‐reported weekly exercise predicts slower declines in brain volume in autosomal dominant Alzheimer's disease (ADAD). Greater self‐reported weekly exercise predicts slower accumulation of brain amyloid beta in ADAD. Associations varied depending on closeness to estimated symptom onset.
Application of high‐density 2D receiver coil arrays for improved SNR in prostate MRI
Riederer, Stephen J. , Borisch, Eric A. , Du, Qingshuo, Froemming, Adam T. , Hulshizer, Thomas C., McGee, Kiaran P. , Robb, Fraser , Rossman, Phillip J. , Takahashi, Naoki , Riederer, Stephen J , Takahashi, Naoki , Kawashima, Akira

Mayo Clinic

Magnetic Resonance in Medicine | September 26, 2024 | Volume: 93 | Issue: 2 | Pages: 850-863

10.1002/mrm.30289 | PMID 39322985 Get It

AbstractPurposeTo study if adaptive image receive (AIR) receiver coil elements can be configured into a 2D array with high (>45% by diameter) element‐to‐element overlap, allowing improved SNR at depth (0.7–1.5× element diameter) versus conventional (20%) overlap.MethodsAn anterior array composed of twenty 10‐cm diameter elements with 45% overlap arranged into a 4 × 5 grid and a similar 3 × 7 twenty‐one‐element posterior array were constructed. SNR and g‐factor were measured in a pelvic phantom using the new high‐density (HD) arrays (41 total elements) and compared to vendor AIR‐based arrays (30 total elements) with conventional overlap. T2‐weighted fast‐spin‐echo (T2SE) images acquired using both arrays were compared in 20 subjects. SNR was estimated in vivo. Results were compared blindly by three uroradiologists using a five‐point scale. Images using the HD arrays were also compared to a set of images acquired over a range of acceleration factors (R = 2.0, 2.5, 3.0) with the conventional arrays.ResultsSNR within the phantom was on average 15% higher for R = 1.0, 1.5, and 2.0 using the HD arrays. Across the 20 subjects SNR within the prostate was 11% higher and assessed radiologically as significantly higher (p < 0.001) for the HD versus conventional arrays. At all acceleration factors the new HD arrays outperformed the conventional arrays (p ≤ 0.01), allowing increased R for similar SNR.ConclusionAIR elements can be configured into 2D arrays with high (45%) element‐to‐element overlap, consistently providing increased SNR at depth versus arrays with conventional (20%) overlap. The SNR improvement allows increased acceleration in T2SE prostate MRI.
Response to Comment on A Method for Continuous Surgeon Improvement in Rectal Cancer
Merchea, Amit , Dozois, Eric J. , Dozois, Eric, Ferrari, Davide , Violante, Tommaso , Vierkant, Robert A. , Larson, David W.

Mayo Clinic

Annals of Surgery Open | September 25, 2024 | Volume: 5 | Issue: 4 | Pages: e494

10.1097/as9.0000000000000494 | PMID 39711687 Get It